| Literature DB >> 11937781 |
Panchatcharam Manikandan1, Miriyala Sumitra, Dilly Ashok Kumar, Chandrasekar Gayathri, Natarajan Arutselvan, Bhakthavatsalam Murali Manohar, Rengarajulu Puvanakrishnan.
Abstract
A novel tetrapeptide derivative Boc-Lys(Boc)-Arg-Asp-Ser(tbu)-OtBu (PEP1261) has been tested in vivo in isoproterenol (ISO) hydrochloride (HCl)-induced myocardial necrosis in rats. ISO x HCl induces myocardial necrosis in rats which is accompanied by the distinct increase in heart weight, marked electrocardiographic changes, increase in the levels of serum marker enzymes and lipid peroxides and decrease in the levels of antioxidants. PEP1261 (5 mg/kg body weight i.p.) pre- and post-treatment effectively decreases serum marker enzyme levels, while the electrocardiographic changes get restored towards normalcy. PEP1261 also inhibits the action of the free radicals toxicity by increasing the levels of antioxidants and histological studies confirm the above findings. This study shows that PEP1261 could serve as an excellent cardioprotective agent possessing membrane-stabilizing action. Copyright 2002 S. Karger AG, BaselEntities:
Mesh:
Substances:
Year: 2002 PMID: 11937781 DOI: 10.1159/000056194
Source DB: PubMed Journal: Pharmacology ISSN: 0031-7012 Impact factor: 2.547